- NYSDOH AI: Bicillin L-A Manufacturing and Supply Shortage Coinciding with Continued Syphilis Increases (6/6/23)
- NYSDOH AI: Call for Abstracts: 2023 Ending the Epidemic Summit & World AIDS Day Events (6/1/23)
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (5/23/23)
- NYSDOH AI Dear Colleague Letter: Transition of pharmacy benefits in the New York State Medicaid program from Managed Care to the new NY Medicaid Pharmacy Program (NYRx) (4/20/23)
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (4/13/23)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (4/11/23)
- CEI: NYS Medical Providers—2023 CEI Annual Survey (4/11/23)
- FDA Approves First Over-the-Counter Naloxone Nasal Spray (3/29/23)
- HIVinfo: Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (3/23/23)
- NYSDOH Fact Sheet: Xylazine: What Clinicians Need to Know (3/9/23)